Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: blake1 who wrote (1145)	2/26/1998 10:09:00 PM
From: Gurupup	Respond to of 5736

I have had the opportunity to go over the entire research report with CCSI. It is basically one of the best research reports that money could buy. If I were an analyst or a money manager, which I am, I would have a few prerequisites in recommending a new idea for purchse, or in this case a short sale. I might consider talking to the management of the company in question. In this instance it would be talking to Darby Macfarlane, and listening to what she has to say. Next I would try and consult experts in the field, and an internationally recognized expert in Bilirubin infant jaundice is Dr, Jeffrey Maisels. The major drug firms consider him the best authority in the United States. Ironically, he just joined the CCSI medical advisory board. In the past he was approached by both Minolta and SPRX, but stated unequivocally that CCSI's technology was the leader, and would become the industry standard, and the other technologies were not in same ballpark. After reading this report probably ten times, I am totally convinced that Dr. Reese is totally clueless about CCSI, and it is very obvious that this is a planted, set up job, by the shorts, but it is so poorly done, poorly written. It is the writings of a 3 year old. It just doesn't make any sense. It looks like she and the 3 Musketeers, cut and pasted 10 Qs and 10Ks, and did absolutely no research.. They took old documents from the garbage to write a report that does not qualify as garbage. I really hate to sugarcoat it, but I love a fair fight, but these people are just plain sleazy. Writers, and poor writers for hire. Let me give you some of the key points in report. My boots are only so high. Q=Quote of Dr. Reese's peices A=Extensive due dilligence from yours truly. Q . CCSI's history of collaborations with various cosmetic companies has repeatedly ended without success. A . CCSI had A collaboration with AVON a number of years ago . AVP breached the contract CCSI took them to court, and prevailed in a out of court settlement. Q.CCSI researched and developed and obtained FDA approval for its Colormate 111 infant bilirubin meter BEFORE it analyzed the infant bilirubin testing market or market demand for this type of product. A. Categorically untrue! CCSI had in fact developed market models before obtaining FDA approval, and after obtaining approval was estatic to learn after numerous meetings with potential licensing partners, that their models were in fact conservative, and in fact the market is much, much larger. Q. CCSI's Colormate 111 will compete against other advanced-technology bilirubin meters that are avaialbe in the US prior to Colormates US commercial launch. A. Absolutely incorrect. Who? CCSI's deal with an licensing partner is imminent, and that would require for SPRX to get through Phase 111 trial, file a 510k with the FDA, and get approval, sign a deal, all in the next 30 days. Get a life people, what turnip truck did you come down in? Do only morons read your research, or do any of your clients have to think? Q.CCSI has no establsihed medical marketing partner or distribution channels,etc........................ A. True, see A above. Imminent is the operative word. continued.......

To: blake1 who wrote (1145)	2/26/1998 10:30:00 PM
From: rogermci®	Respond to of 5736

Blake...How about a toll free number for Avalon of 888-999-2856 as I would sure hate to see anybody waste any money on this pond scum. I happened to get this number from a solicitation from these shysters because I kept the info in my Boca Raton file. I keep this file so I remember not to do business with these types. You can e-mail Cathy direct at creese@avalonresearch.com. She can also answer any and all questions about ingrown toenails. Roger

To: blake1 who wrote (1145)	2/26/1998 10:42:00 PM
From: Gurupup	Read Replies (1) \| Respond to of 5736

Q. CCSI has stated it will take 3-4 years to develop the market. CCSI stated they will not begin clinical trial protocols for other "chromatic diseases until the Colormate 111 launch. A. CCSI's partner thinks it will take 3-4 years to completely sell into the world wide markets. Is that what you meant Dr. Reese? As for the other trials, yes it is reasonable to assume with around the clock negotations going on to find a partner other parts of the business can wait. Q CCSI has financed its operations throught its original IPO, numerous private placements, at a discount, etc........ No significant revenues have ever been developed. A. Gee, Dr Reese, can't fool you for a minute can we. I bet you went and stole that info from public documents, right you clever devil. To think that some of your clients said you couldn't read. Golly gosh darn. Q..NOW we get to the real meat, or spam in this report. CCSI vs SPRX. CCSI is bigger than SPRX and it just isn't fair. Reese's pieces and her little band of merry thieves wants justice, so first lets make a deal with some nasty kids to help slam dunk CCSI, now lets put together a quick and real dirty reasearch piece. But, we better make sure what we tell guys in the shop, because one of the idiots might tell someone, Oh yea, we put it out, but we could change our opinion on a dime. I wonder if he meant, "if you pay me a dime".To think that they didn't even know the new symbol until they got a deal to write the report. Oops!!!! Shhhh! Reese's pieces just made a mistake on page 3 of her Pulitzer prize winner. This is a quote. Dental applications may also offer a future opportunity for CCSI's technology. CCSI identified and been in discussion with medical companies for distribution of the Colormate111, but currently no agreements have been announced. CCSI is working on remaining regulatory requirements, preparation of training manuals, promotional materials and software programs, etccc......... Hey Reese's pieces isn't this something you do when your business is about to take off, and you are close to signing a worldwide deal?? Those really seem like STUPID reasons to short the stock, were you paid for that paragraph also? The rest is more of the same BS, poorly thought out, but Reese's pieces had a real deadline, because the stock was going up every day. I spoke to Darby at some length, and she was stunned that this type of report could be written without her knowledge, without Reese's pieces going over the info she asked for THIS week. She probably got it yesterday, the kit they send out to interested shareholders. Never went back for information. There are offers for the bilirubin device, and Beware the Ides of March, the deal is imminent. This was a classic bucket shop, chop shop job. Reese's pieces and her merry band of thieves, really rank amatuers. You know David S is probably smart enough or shady enough to be a runner at Avalon Research Group Inc. Suddenly, the plot thickens.